IOL Chemicals and Pharmaceuticals Limited, a top manufacturer of pharmaceuticals and specialty chemicals, has named Vikas Vij as its new Chief Executive Officer. This appointment, which takes effect on April 3, 2023, is expected to drive the company’s growth in both domestic and international markets. With a 30-year career in the pharma industry, including leadership positions at Cipla, Ranbaxy, GVK Biosciences, Alembic Pharmaceuticals, Sun Pharma, and Apollo Hospitals, Vij brings a wealth of experience to the role.
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, said, “We’re thrilled to welcome Vikas Vij as CEO of IOL Chemicals and Pharmaceuticals. He’s a proven leader with a track record of driving sales and scaling businesses in the pharmaceutical and specialty chemicals sectors. His expertise will help us drive transformational growth for IOL, both in India and in advanced and emerging markets.”
Vij, who takes over from Dr. Sanjay Chaturvedi, added, “I’m excited to work with the talented team at IOL to drive its next phase of growth. It’s an honor to lead a company that is making a significant impact on people’s lives and on the growth of the Indian Pharmaceutical Industry.”
IOL Chemicals and Pharmaceuticals is listed on the National Stock Exchange of India and the BSE and is a major player in the specialty chemicals space. The company’s product portfolio includes APIs such as Ibuprofen and specialty chemicals like Ethyl Acetate, and it has a wide presence across major therapeutic categories. With a world-class facility, IOL Chemicals and Pharmaceuticals is committed to sustainability and has an approved Effluent Treatment Plant with a Zero Liquid Discharge system and a 17 MW captive Co-Generation plant.